Biofin Italy was established in 1989 as a Chemical/Biotech Company based in Milan, Italy. Biofin has evolved its activities into Management Consulting specialized in the “Chemical/Biological” driven industries: health care, active ingredients, pharmaceutical, biotech, agrochemicals, and adjuvant….

Biofin has developed its globalization deployment through an equity participation in existing companies in the USA (1991), Australia (1997), China (1998), Hungary (1999), Italy (2000) as well as the Middle East (2005).

Biofin Pharma Middle East Sarl, has started its operations in 2005, as a Pharmaceutical company to distribute third party products (Pharmaceuticals, cosmetics, dentistry….) in the Middle East, with its regional office located in Beirut - Lebanon.

Since its inception, Biofin has focused on the pharmaceutical products with a demonstrated “Medical Need” to build its reputation.

This singular focus has allowed the Company to leverage its resources hence maximizing its effectiveness in building enduring relationships with Health Authorities and medical practitioners in various countries in the Middle East (Lebanon, Jordan, Emirates, Saudi Arabia, Kuwait).

Biofin’s principal activities including effective marketing pharmaceutical products and related services, are geared towards the treatment of symptoms in a number medical specialities: eye diseases and disorders, such as glaucoma, urinary tract infection, Dental care… During its short history, Biofin has actively targeted exclusive distribution rights for quality products and companies in North America, Europe and Japan. This branch of Biofin primarily focuses its operations within the Middle East geographical area

All activities underscore the Company’s single, well-defined Mission, which is to improve the quality of care and health needs of patients in the medical fields of concern by providing effective therapies and medical solutions for patients and specialized caregivers.